The company argues that claims of underperformance should be judged against a meaningful, comparable benchmark.

The minister responsible for drug-buying agency Pharmac is doubling down on his call for it to make greater use of artificial ...

The carrier, who works at an Alabama post office, sued the Postmaster General and the United States Postal Service in federal ...

Tango Therapeutics' strong 2026 rally reflects promising clinical progress, but its premium valuation puts upcoming study ...

Independent, vendor-agnostic survey benchmark evaluates NHS EPR advisory firms across optimisation, workflow redesign, implementation assurance, interoperability, data, managed support, trust and ...

A former Texas parole officer says she was fired because she was pregnant - and that her employer changed the charge used to ...

The tables have turned for the U.S. biosimilars market. With more than a decade since the first FDA biosim approval, strong launches to biologic copies to AbbVie’s Humira, J&J’s Stelara and ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

When torrential rains submerged large parts of Accra on June 29, the floods exposed something deeper than blocked drains.

Following semaglutide's approval, poison center reports of GLP-1 RA exposures doubled, revealing critical trends in patient ...

Avadel acquisition adds LUMRYZ sales momentum; alixorexton Phase 2/3 data supports growth. Click for this ALKS stock update.

The investment trust highlighted gains from stakes in global companies controlling 'pinch points' amid AI bottlenecks and ...